Hess M E, Shanfeld J, Levine N R
Recent Adv Stud Cardiac Struct Metab. 1975;10:81-8.
The effect of verapamil on myocardial contractility, heart adenosine 3', 5'-monophosphate (cyclic AMP) and cardiac phosphorylase a activity was studied in isolated perfused rat hearts. In a concentration of 0.025 mug/ml, verapamil decreased force of contraction 50% and caused a significant fall in heart cyclic AMP within 4 to 5 min after perfusion with the drug was begun. When perfusion of the heart with medium containing verapamil was continued for 60 min, contractile force gradually returned to control. at the end of 60 min of perfusion with verapamil, the myocardial concentration of cyclic AMP was not different from that measured in hearts perfused with contro medium for a similar time period. Isoproterenol, given at the point of maximal contractile depression induced by verapamil, restored normal force of contraction and raised cardiac cyclic AMP to the same level as that observed when the catecholamine was given to untreated hearts; When methoxamine was administered to hearts depressed by verapamil, contractility returned to normal, but cyclic AMP content remained below control values.
在离体灌注大鼠心脏中研究了维拉帕米对心肌收缩力、心脏3',5'-单磷酸腺苷(环磷酸腺苷)及心脏磷酸化酶a活性的影响。在浓度为0.025微克/毫升时,维拉帕米使收缩力降低50%,并在开始用该药灌注后4至5分钟内使心脏环磷酸腺苷显著下降。当用含维拉帕米的培养基继续灌注心脏60分钟时,收缩力逐渐恢复至对照水平。在维拉帕米灌注60分钟结束时,心肌环磷酸腺苷浓度与在相同时间段内用对照培养基灌注的心脏中测得的浓度无差异。在维拉帕米引起最大收缩抑制时给予异丙肾上腺素,可使收缩力恢复正常,并使心脏环磷酸腺苷升高至与将该儿茶酚胺给予未处理心脏时观察到的相同水平;当将甲氧明给予因维拉帕米而抑制的心脏时,收缩力恢复正常,但环磷酸腺苷含量仍低于对照值。